Banco Bilbao Vizcaya Argentaria, S.A. Regeneron Pharmaceuticals, Inc. Transaction History
Banco Bilbao Vizcaya Argentaria, S.A.
- $10.9 Billion
- Q2 2025
A detailed history of Banco Bilbao Vizcaya Argentaria, S.A. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Banco Bilbao Vizcaya Argentaria, S.A. holds 37,676 shares of REGN stock, worth $22.6 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
37,676
Previous 38,168
1.29%
Holding current value
$22.6 Million
Previous $24.2 Million
18.29%
% of portfolio
0.18%
Previous 0.25%
Shares
23 transactions
Others Institutions Holding REGN
# of Institutions
1,421Shares Held
88.7MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.65 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.07 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.39 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.9 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.3 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $64.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...